Highlights from the fifth annual Genomics Scientific Retreat
On December 12, the Precision Genomics Collaboratory convened its fifth annual Genomics Scientific Retreat in the Trent Semans Center Great Hall, bringing together faculty, staff, and trainees from across Duke University for a full day of discovery, dialogue, and connection. The retreat showcased the breadth of genomics research at Duke—from foundational science to clinical translation.
The program featured two keynote speakers at the forefront of the field. Melissa Haendel, PhD, FACMI, Sarah Graham Kenan Distinguished Professor of Genetics and director of the Translational and Integrative Science Laboratory at UNC–Chapel Hill, shared how a phenomics-first approach can accelerate genomic medicine. Her work spans rare diseases, long COVID, Down syndrome, cancer, and pressing public health challenges such as pandemic response and climate change.
Aravind Asokan, PhD, professor of surgery, molecular genetics and microbiology, and biomedical engineering, and director of gene therapy at Duke University School of Medicine, offered a wide-ranging look at the evolution of gene therapy. Tracing his lab’s journey from engineering adeno-associated viruses to RNA-based strategies across diverse tissues and cell types, Asokan highlighted key milestones, persistent challenges, and what lies ahead for the field.

Beyond the keynotes, attendees heard brief overviews from five core facility directors and staff, gaining insight into the resources available to support genomics research. The retreat also spotlighted emerging investigators: six trainees and junior faculty delivered oral presentations, and 35 additional researchers shared their work during a poster session.
To recognize outstanding work, the top three oral and poster presenters each received $300 in research support.
Congratulations to the Awardees
Oral Presenters
-
Sam Reisman, PhD candidate, Cell Biology
Mismatch tolerance in the gRNA seed region drives potent off-target CRISPRa activity -
Vennesa Valentine, PhD candidate, Pharmacology
Mouse model to conditionally express a diffuse midline glioma–derived mutation in the oncogenic phosphatase PPM1D -
Anvita Kulshrestha, PhD candidate, University Program in Genetics and Genomics
Mitochondrial heterogeneity in sickle cell disease
Poster Presenters
-
Patrick Prochazka, PhD candidate, Molecular Cancer Biology
-
Patrick Rodriguez, Policy Analyst, Duke Margolis Institute for Health Policy
-
Boxun Li, PhD, Postdoctoral Associate, Biostatistics and Bioinformatics